Related resources
Full-text held externally
- PMID: 24532745
- UKPMCID: 24532745
- DOI: 10.7861/clinmedicine.14-1-47
Search for item elsewhere
University researcher(s)
Academic department(s)
Drug therapies in dermatology.
Aslam, Arif; Griffiths, Christopher E M
Clinical medicine (London, England). 2014;14(1):47-53.
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Full-text is available externally using the following links:
Full-text held externally
- PMID: 24532745
- UKPMCID: 24532745
- DOI: 10.7861/clinmedicine.14-1-47
Abstract
This article explores the current and emerging therapies for skin disease, with a particular focus on chronic plaque psoriasis and metastatic malignant melanoma. We discuss the current biological therapies used for psoriasis and those on the horizon, including small molecules and biosimilars. We also summarise the recent advances in the use of novel therapeutic agents in other dermatological diseases and outline the promise of translational research and stratified medicine approaches in dermatology. Better matching of patients with therapies is anticipated to have a major effect on both clinical practice and the development of new drugs and diagnostics.
Keyword(s)
Psoriasis; atopic dermatitis; biological therapies; malignant melanoma; tumour necrosis factor antagonists